Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jason Rose
University of Pittsburgh at Pittsburgh, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Globin Solutions, Inc.
Other : IP rights to UPitt - licensed to Globin Solutions, Inc.
The research conducted under this grant is of commercial interest to Globin Solutions. Dr. Rose holds an ownership interest in Globin Solutions, serves as the company's Chief Executive Officer, and is an inventor of intellectual property licensed to the company that is being evaluated or developed in research funded by this award.
Discovering and Developing Recombinant Molecular Scavenging Agents for the Treatment of Carbon Monoxide Induced Cardiovascular Dysfunction
Narrative There are 50,000 Carbon monoxide (CO) poisoning cases every year in the United States, with many survivors suffering cardiac dysfunction, which is associated with increased long-term mortality. Our lab has developed a CO scavenging agent, recombinant Neuroglobin (rNgb) that directly binds CO from poisoned mitochondria, reversing a major cause of CO pathophysiology and morbidity. The current study will: 1) investigate the basis of the cardiovascular toxicity of CO poisoning; 2) demonstrate the efficacy and safety of a rNgb antidotal therapy and 3) design and develop a second generation CO scavenging based upon a synthetic heme molecule containing peptide.
Filed on October 15, 2018.
Tell us what you know about Jason Rose's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Jason Rose filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jason Rose | University of Pittsburgh at Pittsburgh | Conflict of Interest | Globin Solutions, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.